INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2018

Chronic nicotinamide riboside supplementation is well-tolerated and stimulates NAD+ metabolism in healthy middle-aged and older adults.

In a 2 x 6-week randomized, double-blind, placebo-controlled crossover clinical trial, researchers assessed the effects of chronic supplementation with the NAD+ precursor nicotinamide riboside (NR) in healthy middle-aged and older adults. Chronic NR supplementation was well tolerated and effectively stimulated NAD+ metabolism. The results suggest that future clinical trials should further evaluate the potential benefits of NR for reducing blood pressure and arterial stiffness in this population.

Study type
2 x 6-week randomized, double-blind, placebo-controlled crossover trial
Who was studied
Healthy middle-aged and older adults
What was measured
Tolerability, stimulation of NAD+ metabolism, and physiological function

THE PAPER

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.

Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, Chonchol M, Seals DR. Nat Commun, 2018.

PubMed 29599478 ↗DOI 10.1080/10543409108835010 ↗

Heart & arteriesBlood pressureNutrients & adequacyHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.